Skip to main content

Software and Bios

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

πŸ“Œ Par Technology $PAR β€” Voss Advisors bought $7.10 Million per a new Form 4.

A large, coordinated buy in a beaten-down software name. Size matters here, especially with the stock trying to find its footing after a prolonged drawdown.

πŸ“Œ Flywire $FLYW β€” Voss Advisors bought $3.20 Million per a new Form 4.
 
Back-to-back buys from the same fund point to a thematic bet across payments and software, rather than a one-off trade.

Here’s The Hot Corner, with data from January 7, 2026:

πŸ“Œ Landbridge Company $LB β€” Management group bought $164,630 per a new Form 4.

A smaller, but clean C-suite add as the stock trades near the lower boundary of a completed distribution structure.

πŸ“Œ Disc Medicine $IRON β€” RA Capital increased its stake from 4.54% to 5.90% via a 13G.

A well-known biotech specialist crossing the 5% threshold is notable, particularly as the stock works through a post-run consolidation.

Here’s how we’re trading this sock. 

Disc Medicine is in the process of completing a massive SPAC base, with price retesting the 38.2% Fibonacci retracement. 

 

As long as buyers can hold the 80 level, we want to be involved, targeting 124 as our first objective